Sichenzia Ross Ference Kesner LLP Represents Tonix Pharmaceuticals Holding Corp. in $8 Million Shelf Take Down
Press Release – New York, NY – April 8, 2017 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it has represented Tonix Pharmaceuticals Holding Corp. (“Tonix”), a company that is developing innovative pharmaceutical products to address public health challenges, in connection with its underwritten public offering of 1,800,000 shares of its common stock at an offering price of $4.45 per share of common stock.
Gross proceeds to Tonix from this offering are $8,010,000 before deducting underwriting discounts and commissions and other estimated offering expenses payable by Tonix. Aegis Capital Corp. acted as the sole book-running manager for the offering and Dawson James Securities, Inc. acted as a co-manager.
The Sichenzia Ross Ference Kesner LLP team was led by Partners Marc J. Ross and James M. Turner.
Visit SRF's LinkedIn page
Latest posts by Sichenzia Ross Ference LLP (see all)
- Founding Partner Gregory Sichenzia Featured in Business Insider Discussing the Legal Aftermath for Tesla - September 19, 2018
- Sichenzia Ross Ference LLP Acts as Principal Attorney Liaison for AusCann Group Holdings Ltd on OTCQX Listing - September 15, 2018
- Sichenzia Ross Ference LLP Acts as Principal Attorney Liaison for Zelda Therapeutics Ltd on OTCQX Listing - September 15, 2018